George Lau to Biomarkers
This is a "connection" page, showing publications George Lau has written about Biomarkers.
Connection Strength
0.048
-
Treatment of chronic hepatitis B infection-2017. Liver Int. 2017 01; 37 Suppl 1:59-66.
Score: 0.032
-
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases. Sci Rep. 2017 11 28; 7(1):16482.
Score: 0.008
-
Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure. Liver Int. 2017 10; 37(10):1497-1507.
Score: 0.008